Stress-induced ulcer bleeding in critically ill patients

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Pharmacology

Background:

• Improved ICU care and risk factor knowledge have reduced stress-related bleeding.
• Stress-related mucosal damage (SRMD) prophylaxis is not universally required for all critically ill patients.
• Identifying low-risk patients for whom prophylaxis can be withheld is a cost-effective strategy.

Purpose of the Study:

• To evaluate the efficacy and safety of proton pump inhibitors (PPIs) versus histamine H2-receptor antagonists (H2RAs) for SRMD prophylaxis in critically ill patients.
• To compare intravenous PPIs with other acid-suppressive agents.
• To define appropriate dosing and formulations for PPIs in SRMD prevention.

Main Methods:

• Comparative analysis of intravenous H2RAs and PPIs for preventing clinically important bleeding.
• Assessment of risk factors for stress-induced upper GI bleeding, including mechanical ventilation duration and coagulopathy.
• Review of current evidence on PPI efficacy and safety in critically ill populations.

Main Results:

• Mechanical ventilation >48 hours and coagulopathy are primary risk factors for stress-induced upper GI bleeding.
• Intravenous H2RAs can prevent significant bleeding but tolerance may limit their long-term benefit.
• Intravenous PPIs offer a viable option for prophylaxis, enabling direct comparison with H2RAs.

Conclusions:

• Withholding SRMD prophylaxis in selected low-risk ICU patients is reasonable and cost-effective.
• Further research is needed to establish optimal PPI dosing, evaluate newer formulations, and develop guidelines for PPI use in SRMD prevention.
• Proton pump inhibitors (PPIs) show promise for prophylaxis, but their role relative to H2RAs requires further definition.